Multiple Sclerosis Therapeutics Market Growth Factors, Demand, Future Prospects and Top Key Players
Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system. The immune system attacks the nerves, which causes communication problems between the brain and rest of the body. Immunosuppressant and immunomodulators, along with physiotherapy, are widely used to treat MS.
The scope of the multiple
sclerosis therapeutics market includes drug class, route of
administration, distribution channel, and region. The market for multiple
sclerosis therapeutics is analyzed based on regions such as North America,
Europe, Asia Pacific, Middle East & Africa, and South and Central America.
The report offers insights and in-depth analysis of the multiple sclerosis
therapeutics market emphasizing on various parameters, such as market trends,
technological advancements, market dynamics, and competitive landscape analysis
of leading market players across the globe.
Sample PDF showcases the content structure and
the nature of the information included in the report which presents a
qualitative and quantitative analysis – https://www.theinsightpartners.com/sample/TIPRE00004057/
Leading Multiple Sclerosis Therapeutics Market Players:
- Merck &
Co., Inc.
- Novartis AG
- Bayer AG
- Sanofi
- Bristol-Myers
Squibb Company
- Horizon
Therapeutics plc.
- TEVA
PHARMACEUTICAL INDUSTRIES LTD
- Takeda
Pharmaceutical Company Limited
- F.
HOFFMANN-LA ROCHE LTD.
- Biogen
The report
segments Global Multiple Sclerosis Therapeutics Market as follows:
By Drug Class
- Immunosuppressant
- Immunomodulators
By Route of Administration
- Injectable
- Oral
By Distribution Channels
- Hospital
Pharmacies
- Retail
Pharmacies
- E-Commerce
Drug Class Based Insights
Based
on multiple sclerosis therapeutics drug class, the multiple sclerosis
therapeutics market is segmented into immunosuppressant and immunomodulators.
In 2019, the immunomodulators segment accounted for larger share of the market.
Growth of this segment is attributed to launch of new generic drugs and
increase in adoption of immunomodulators in MS treatment. The immunosuppressant
segment is likely to register higher CAGR during the forecast period.
Route of Administration Based Insights
In
terms of route of administration, the multiple sclerosis therapeutics market is
segmented into injectable and oral. The injectable segment held larger share of
the market in 2019, and same segment is anticipated to register higher CAGR
during the forecast period.
Distribution Channel Based Insights
Based
on distribution channel, the multiple sclerosis therapeutics market is
segmented into hospital pharmacies, retail pharmacies, and e-commerce. The
hospital pharmacies segment held the largest share of the market in 2019, and
the e-commerce segment is anticipated to register the highest CAGR in the
market during the forecast period.
Immediate delivery
of our off-the-shelf reports and pre booking of upcoming studies, through
flexible and convenient payment methods – https://www.theinsightpartners.com/buy/TIPRE00004057/
Multiple Sclerosis Therapeutics Market Segmented by
Region/Country: North America, Europe, Asia Pacific, Middle East & Africa,
and Central & South America
About Us:
The Insight Partners is a one stop industry research
provider of actionable intelligence. We help our clients in getting solutions
to their research requirements through our syndicated and consulting research
services. We specialize in industries such as Semiconductor and Electronics,
Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare
IT, Manufacturing and Construction, Medical Device, Technology, Media and
Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you
would like further information, please
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Comments
Post a Comment